Skip to main content

Save up to 30% on Elsevier print and eBooks with free shipping. No promo code needed.

Save up to 30% on print and eBooks.

Developing Costimulatory Molecules for Immunotherapy of Diseases

1st Edition - May 25, 2015

Author: Manzoor Ahmad Mir

Language: English
Paperback ISBN:
9 7 8 - 0 - 1 2 - 8 0 2 5 8 5 - 7
eBook ISBN:
9 7 8 - 0 - 1 2 - 8 0 2 6 7 5 - 5

Developing Costimulatory Molecules for Immunotherapy of Diseases highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunothe… Read more

Developing Costimulatory Molecules for Immunotherapy of Diseases

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Developing Costimulatory Molecules for Immunotherapy of Diseases

highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunotherapy using either humanized antibodies against CD80, CD86, and other costimulatory molecules or CD28 fusinogenic proteins in the treatment of diseases, including allergies, asthma, rheumatoid arthritis, multiple sclerosis, lupus nephritis, severe psoriasis, vulgaris tuberculosis, thopoid, transplantation therapeutic, cancer, and inflammation.

The text aims to provide the latest information on the complex roles and interactions within the CD28 and B7 costimulatory families, with the hope that targeting these families will yield new therapies for the treatment of inflammation, autoimmunity, transplantation, cancer, and other infectious diseases.